Investor Presentation
Filed with ASX · · 15 pages · English
EVE Health Group Limited on 6ix
In the deck
Earlier from EVE Health
- Prospectus
- EVE Placement Update
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- Trading Halt
- EVE Advances Reformulated Drugs Targeting Global Markets
Later from EVE Health
- Appointment of Chief Executive Officer
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
- Response to ASX Price and Volume Query
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health